PRCT
Procept BioRobotics Corp

969
Loading...
Loading...
News
all
press releases
ISRG Stock Down More than 13% in 3 Months: How to Play the Stock?
Intuitive Surgical shares are down 13% in three months as margin pressures weigh on the stock, but strong procedure growth keeps its long-term story intact.
Zacks·16d ago
News Placeholder
More News
News Placeholder
SP Platform's 88% Procedure Growth: The Next Frontier for ISRG?
Intuitive Surgical's SP platform posts 88% procedure growth in Q2, driven by a 112% surge in Korea and expanding adoption in colorectal and thoracic surgery.
Zacks·1mo ago
News Placeholder
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates
PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of +14.63% and -0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates
AxoGen (AXGN) delivered earnings and revenue surprises of +100.00% and +7.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Si-Bone (SIBN) Reports Q2 Loss, Beats Revenue Estimates
Si-Bone (SIBN) delivered earnings and revenue surprises of +26.32% and +0.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Tops Revenue Estimates
Envoy Medical, Inc. (COCH) delivered earnings and revenue surprises of -10.34% and +39.29%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know
PROCEPT BioRobotics (PRCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2mo ago
News Placeholder
Short seller Spruce Point targets Procept on overestimation of market size
Investing.com -- Short seller Spruce Point Capital Management expressed concern over Procept Biorobotics Corp (NASDAQ:PRCT)’s growth prospects, market size estimates, and safety of its robotic surgical procedures.
investing.com·9mo ago
News Placeholder
Small and Micro-Cap Movers: Key News, Market Reactions, and Insider Chatter
Today’s most impactful small-cap stock updates, with exclusive rumors, insights, and analysis from StockTwits
Stocktwits Contributor·11mo ago
News Placeholder
Procept BioRobotics Stock Surges After Strong Q3 Earnings, Outlook Boost: Retail Cheers On
Procept raised its fiscal year 2024 revenue guidance to a range of $222.5 million to $223 million, above the consensus of $217.06 million.
Stocktwits·11mo ago

Latest PRCT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.